The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates ...
Regulatory troubles continue for Sun Pharma as the drug manufacturer’s Mumbai unit ... before taking any investment decisions. Advisory Alert: It has come to our attention that certain ...
On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
Dadra's specialization lies in the production of oral solid dosage forms and the manufacture of the blockbuster drug Revlimid, a vital revenue driver for Sun ... said Advisory Alert: It has ...
Lupin, Sun Pharma recall Lisinopril and Clonazepam respectively in the US market The Mumbai-based drug maker Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg, which is used to ...
Sun Pharmaceutical Industries witnessed a 3.4% decline in its shares as the US FDA categorized its Dadra facility as 'official action indicated' (OAI), suggesting recommended regulatory or ...
Law Offices of Howard G. Smith announces an investigation on behalf of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) (NASDAQ: SUPN) inv ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...